On September 20, 2018, Maquet/Getinge initiated a worldwide recall of approximately 5,223 Maquet/Getinge Cardiosave Intra-Aortic Balloon Pumps (IABP) sold by Datascope Corp., for a potential interruption and/or inability to start therapy to the patient at altitudes above 3200 feet above sea level. Click title to continue reading...
On September 20, 2018, the FDA completed a review of all postmarketing reports of deaths and serious adverse events (SAEs) reported with the use of Nuplazid (pimavanserin), a medication to treat the hallucinations and delusions of Parkinson’s disease psychosis. Click title to continue reading...
On September 20, 2018, a CDC study found that the U.S. burden of Alzheimer’s disease and related dementias (ADRD) will double by 2060. Alzheimer’s disease is the fifth most common cause of death for Americans ages 65 years and older. It is an irreversible, progressive brain disorder that slowly destroys memory and, eventually, a person’s ability to perform even the simplest tasks, such as bathing, feeding, and dressing. Click title to continue reading...